Two studies shed new genetic insights into thyroid cancer in Indian patients
The indentification of two critical markers — DUOX2 and THRA — will help in better predicting which patients might face aggressive thyroid cancer disease or recurrence. For papillary thyroid cancer, this might mean developing targeted therapies for the novel subtype (iBR) or using DUOX2 for early detection. For anaplastic thyroid cancer, targeting THRA-driven plasticity could lead to breakthroughs for a cancer with few options
Read More